
-
Chainsaw-wielding Musk savors Trump's return to White House
-
Trump meets with Tiger, PIF and PGA Tour bosses to reunite golf
-
Roma reach Europa League last 16 as 10-man Ajax scrape through
-
MLS hoping for World Cup buzz in 30th season
-
Bolivia's Morales launches 4th presidential bid, defying term limit
-
Harris Reed opens with 'rebellious' show at London Fashion Week opening
-
Stocks mostly fall on tepid Walmart outlook, geopolitical worries
-
Argentine court dismisses charges against 3 accused in death of singer Liam Payne
-
Musk in X spat with Danish astronaut over 'abandoned' ISS crew
-
Bond franchise shake-up moves spy into Amazon stable
-
New York seeks hundreds of millions of dollars in 'vaping epidemic' case
-
Dybala double leads Roma into Europa League last 16
-
'Lot of fun' - Vance savors Trump's return to White House
-
Mavs' Davis 'making good progress' after adductor strain
-
Moon or Mars? NASA's future at a crossroads under Trump
-
Bucks' Portis banned 25 games for violating NBA anti-drug policy
-
England captain Itoje glad of 'Superman' Hill's help against Scotland
-
EU trade chief says tariff reciprocity 'must work for both' sides
-
Curfew imposed after bomb attacks in Colombia injure six
-
Andreeva, 17, stuns Swiatek to reach Dubai semis with landmark win
-
Wembanyama to miss rest of NBA regular season with blood clot
-
Pope's condition 'slightly improving' on seventh day in hospital
-
Comeback hero Shami says wicket-taking mindset alive
-
Spotify adds more AI-generated audiobooks
-
Alcaraz dumped out by Lehecka in Qatar Open quarters
-
Victor Wembanyama to miss rest of NBA regular season: Spurs
-
Scotland coach Townsend eager to extend England run as Russell passed fit
-
Five things to know about Bond, James Bond
-
Vance savors Trump's 'fun' return to White House
-
Bavuma wary of Afghanistan challenge in Champions Trophy
-
Pope 'sitting up, eating' in seventh day in hospital
-
'Fixated' man who approached Raducanu is given restraining order
-
Hong Kong's oldest pro-democracy party prepares to shut down
-
Andreeva, 17, stuns Swiatek to reach Dubai semi-finals with landmark win
-
Mexico says won't accept US 'invasion' in fight against cartels
-
Burundi forces flee DR Congo as conflict sparks refugee wave
-
Stocks in the red as investors worry about growth and inflation
-
Gill ton powers India to win over Bangladesh in Champions Trophy
-
Ireland match no time to experiment, says Wales coach Sherratt
-
Bomb attacks in Colombia injure six
-
Netflix says to spend $1 billion producing content in Mexico
-
Bond franchise shifts to Amazon as Broccoli family steps back
-
Unfair? Figures belie Trump's claims on EU trade balance
-
Putin hails Russia's huge number of 'terror' convictions
-
Israel denounces Hamas as 'monsters' for staging of hostage bodies handover
-
Rublev downs de Minaur on eighth match point in Qatar
-
Teenager kills two women in knife attack at Czech shop
-
Trump goads '51st state' Canada ahead of hockey grudge match
-
EU trade chief says tariff reciprocity 'must work for both' bloc and US
-
Africa's first G20 meeting opens with call for 'cooperation'

Philips losses worse than expected in 2024
Philips on Wednesday posted worse-than-expected losses in 2024, as the Dutch medical device maker bids to turn the page on a damaging recall of faulty sleep machines.
The firm reported a net loss of 698 million euros for the full year 2024, compared to the 463-million-euro loss it posted in 2023.
Chief executive Roy Jakobs noted "double-digit declines in demand in both consumer and health systems in China" as well as "a persistently challenging macro environment" as reasons for the losses.
Analysts polled by the company were expecting a full-year loss of 65 million euros and sales of 18.0 billion euros.
Total sales for 2024 came in as forecast at 18.0 billion euros, compared to the 18.1 billion euros gained in 2023.
In November, the firm had lowered its full-year sales target, blaming a drop in demand from Chinese hospitals. That caused stocks to plunge by more than 11 percent.
Once famous for making lightbulbs and televisions among other products, Amsterdam-based Philips in recent years has sold off subsidiaries to focus on medical care technology.
Since 2021, the company has been battling a series of crises over its DreamStation machines for sleep apnoea, a disorder in which breathing stops and starts during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foams and fears it could potentially cause cancer.
In April, it announced it had reached a $1.1 billion deal to settle US lawsuits from the faulty machines.
Philips got a boost the day before the results when the French agency for medical safety said it could sell its respirators in the country again.
"We strengthened our fundamentals and resolved significant US litigation relating to the Respironics recall," said Jakobs.
Looking ahead, the firm said it expected sales growth of between one and three percent.
These results would be hit by a "mid-to high-single-digit decline in China," the company warned.
"We remain confident in our long-term plan," said Jakobs.
For the fourth quarter, Philips posted a net loss of 333 million euros on sales of 5.0 billion euros.
Analysts had forecast fourth-quarter profits of 302 million euros and sales of 5.1 billion euros.
The firm has continued to shed jobs. It employed 67,823 people at the end of 2024, compared to 69,656 at the end of 2023.
B.Shevchenko--BTB